Characteristics of Speakers at US FDA Advisory Committee Meetings on Drug Approval
Year: 2025
Type: article
Study design: Observational Study
Abstract: This cross-sectional study assesses whether the characteristics of people who spoke at US Food and Drug Administration Human Drug Advisory Committee meetings on new drug approvals were associated with recommendations for drug approval.
Source: JAMA Internal Medicine
Authors: Leah Z. Rand, Helen Mooney, Dongzhe Hong, Daniel Eisenkraft Klein, Aaron S. Kesselheim, Benjamin N. Rome
Institutions: Brigham and Women's Hospital, Harvard University
Language: English
Subfield: Pharmacology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W4416580507